The global bioburden testing market is projected to grow at a CAGR of 12.3%, in terms of value, from 2020 to reach USD 1,611.8 Million by 2028. Bioburden inspection, or absolute viable count testing, is measuring the rate of microbial contamination on a product or inside it. Accumulation of bioburden can be generated from the raw materials used in the manufacturing process or added through workers or manufacturing operations. Factors driving the growth of the target market include rising governm...